Lymphoma Non-hodgkin
📧 Sign up to get email alerts when something new happens for Lymphoma Non-hodgkin.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2020-06-24EMA Application withdrawn: Rituximab Mabion (rituximab) — Mabion Spolka Akcyjna
The EMA application for Rituximab Mabion (rituximab) by Mabion Spolka Akcyjna has been withdrawn.